CCR3 and type 1 diabetes mellitus: According to the study of Lohmann et al. [23], there was no difference for the Th2-associated chemokine receptor CCR3 in CD3+ lymphocytes between newly diagnosed T1DM patients, long-existing T1DM patients and healthy individuals.